Meta-Analysis Gaining Status In Science And Policymaking

Despite lingering debates, statistical method wins acceptance and exerts influence among researchers. Meta-analysis-a statistical method of quantitatively combining and synthesizing results from individual studies-has begun to exert an influence on science, its practice, and its use in policymaking, despite early opposition and skepticism. One recent example that has attracted considerable media attention concerns the use of "fen-phen" (fenfluramine/phentermine), the popularly prescribed obesi

Written byStephen Hoffert
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share


Despite lingering debates, statistical method wins acceptance and exerts influence among researchers.
Meta-analysis-a statistical method of quantitatively combining and synthesizing results from individual studies-has begun to exert an influence on science, its practice, and its use in policymaking, despite early opposition and skepticism. One recent example that has attracted considerable media attention concerns the use of "fen-phen" (fenfluramine/phentermine), the popularly prescribed obesity control drugs. A Mayo Clinic meta-analysis of 24 users with rare valvular disease alerted United States health officials to the potential risks of fen-phen in July. A health advisory issued by the Food and Drug Administration (FDA) on July 8 turned up 58 more cases of heart valve damage in users of the drug. FDA has requested warning labels on all prescriptions, and Wyeth-Ayerst Laboratories, a Philadelphia-based maker of fenfluramine, has announced sponsorship of a study of 1,200 users.

Harris Cooper, a professor at the Center for Research ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies